K. Reich, M. Lebwohl, C. Paul, M. Ropke, M. Rosen, and K. Hansen, “Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis”, J of Skin, vol. 2, no. S1, p. S1, Feb. 2018.